title: The DARTNet Institute: Seeking a Sustainable Support Mechanism for Electronic Data Enabled Research Networks.
abstract: BACKGROUND
  Clinical data research networks require large investments in infrastructure support to maintain their abilities to extract, transform, and load data from varied data sources, expand electronic data sources and develop learning communities.
  
  
  METHODS
  This paper outlines a sustainable business model of ongoing infrastructure support for clinical data research activities. The DARTNet Institute is a not-for-profit 501(c)(3) organization that serves as a support entity for multiple practice-based research networks. Several clinical data research networks working closely with a professional society began collaborating to support shared goals in 2008. This loose affiliation called itself the "DARTNet Collaborative." In 2011, the DARTNet Institute incorporated as an independent, not-for-profit entity. The business structure allows DARTNet to advocate for all partners without operating its own practice-based research network, serve as a legal voice for activities that overlap multiple partners, share personnel resources through service contracts between partners, and purchase low-cost (nonprofit rate) software.
  DARTNet's business model relies upon four diverse sources of revenue: (1) DARTNet licenses and provides access to a propriety software system that extracts, transforms, and loads data from all major electronic health records (EHRs) utilized in the United States, and which also provides clinical decision support for research studies; (2) DARTNet operates a recognized, national professional-society-quality improvement registry that enables organizations to fulfill Meaningful Use 2 criteria; (3) DARTNet provides access to data for research activities that are funded by direct research dollars, provided at prices that generate excess revenue; and (4) DARTNet provides access to large primary care datasets for observational studies and pregrant analyses such as for sample size development. The ability of the system to support pragmatic trials will be described.
  
  
  CONCLUSIONS
  The DARTNet model facilitates the use of direct grant dollars to generate revenue to support the overall enterprise through a purchased services arrangement. Other services provided through subcontracting provide facilities and administration fees as well as direct dollars to support the system. The flexibility of the business model overcomes the complicated financial arrangements and governance requirements of many professional associations and academic medical centers.
authors.affiliation: University of Colorado School of Medicine.
authors.forename: Wilson D
authors.initials: WD
authors.lastname: Pace
authors.affiliation: University at Buffalo.
authors.forename: Chester H
authors.initials: CH
authors.lastname: Fox
authors.affiliation: Rockhurst University.
authors.forename: Turner
authors.initials: T
authors.lastname: White
authors.affiliation: American Academy of Family Physicians.
authors.forename: Deborah
authors.initials: D
authors.lastname: Graham
authors.affiliation: University of Colorado School of Medicine.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Schilling
authors.affiliation: University of Colorado School of Medicine.
authors.forename: David R
authors.initials: DR
authors.lastname: West
keywords: Sustainability; research networks; shared resources
references.citation: Cancer Control. 2005 Jul;12(3):186-95
references.pmid: 16062166
references.citation: Ann Fam Med. 2005 Jul-Aug;3 Suppl 2:S2-3
references.pmid: 16049076
references.citation: Ann Fam Med. 2005 May-Jun;3 Suppl 1:S5-11
references.pmid: 15928219
references.citation: Implement Sci. 2013 Jan 24;8:12
references.pmid: 23347882
references.citation: EGEMS (Wash DC). 2013 Oct 07;1(1):1027
references.pmid: 25848567
references.citation: J Am Board Fam Med. 2006 Jan-Feb;19(1):93-7
references.pmid: 16492011
references.citation: J Clin Epidemiol. 2009 May;62(5):461-3
references.pmid: 19348970
references.citation: Implement Sci. 2013 Aug 08;8:88
references.pmid: 23927603
references.citation: J Am Board Fam Med. 2012 Sep-Oct;25(5):582-93
references.pmid: 22956694
references.citation: Implement Sci. 2006 Feb 23;1:4
references.pmid: 16722571
references.citation: J Am Board Fam Med. 2014 Jan-Feb;27(1):19-25
references.pmid: 24390882
references.citation: Am J Manag Care. 2004 Sep;10(9):643-8
references.pmid: 15515997
references.citation: Med Care. 2010 Jun;48(6 Suppl):S39-44
references.pmid: 20473193
references.citation: Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1017-21
references.pmid: 6970075
references.citation: Obstet Gynecol. 1991 Apr;77(4):498-503
references.pmid: 2002969
references.citation: J Am Board Fam Pract. 1988 Jan-Mar;1(1):15-23
references.pmid: 3414385
references.citation: Ann Fam Med. 2011 Jan-Feb;9(1):63-8
references.pmid: 21242563
references.citation: Am J Public Health. 2012 Jul;102(7):1274-81
references.pmid: 22594758
references.citation: Am J Med. 2013 Apr;126(4):327-335.e12
references.pmid: 23507206
references.citation: J Am Board Fam Med. 2014 Jan-Feb;27(1):78-86
references.pmid: 24390889
references.citation: Ann Fam Med. 2007 Jan-Feb;5(1):39-47
references.pmid: 17261863
references.citation: J Clin Epidemiol. 2009 May;62(5):499-505
references.pmid: 19348976
references.citation: J Allergy Clin Immunol. 2014 Jan;133(1):27-33
references.pmid: 24369796
references.citation: J Am Med Inform Assoc. 2010 Mar-Apr;17(2):124-30
references.pmid: 20190053
references.citation: Annu Rev Public Health. 2013;34:235-51
references.pmid: 23297655
references.citation: J Public Health Manag Pract. 2008 Mar-Apr;14(2):117-23
references.pmid: 18287916
references.citation: J Am Board Fam Med. 2011 Sep-Oct;24(5):534-42
references.pmid: 21900436
references.citation: JAMA. 2008 Jan 9;299(2):211-3
references.pmid: 18182604